scholarly article | Q13442814 |
P2093 | author name string | Jeffrey Katz | |
P2860 | cites work | Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine | Q24685766 |
Probiotics in inflammatory bowel disease: possible mechanisms of action | Q34423265 | ||
Probiotic therapy of intestinal inflammation and infections. | Q34554746 | ||
Therapy of ulcerative colitis | Q36036581 | ||
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression | Q38442953 | ||
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis | Q59120549 | ||
Prevention is the best defense: probiotic prophylaxis of pouchitis | Q73351425 | ||
P433 | issue | 1 | |
P921 | main subject | probiotics | Q1816730 |
P304 | page(s) | 16-18 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Gastroenterology & hepatology | Q26842161 |
P1476 | title | The Role of Probiotics in IBD. | |
P478 | volume | 2 |
Search more.